Improved mood states with lamotrigine in patients with epilepsy

Epilepsy and Behavior

Volumn 5, Issue 5, 2004, Pages 702-707

  Cramer, Joyce A ^a   Hammer, Anne E ^b   Kustra, Robert P ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GLAXOSMITHKLINE   (United States)

Author keywords

Clinical trial; Depression; Epilepsy; Lamotrigine; Monotherapy; Mood

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; GABAPENTIN; LAMOTRIGINE; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; TOPIRAMATE; VALPROIC ACID; ANTIDEPRESSANT AGENT; TRIAZINE DERIVATIVE;

ADULT; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE CONTROL; DOSE RESPONSE; DRUG MECHANISM; DRUG POTENTIATION; DRUG RESPONSE; DRUG WITHDRAWAL; EPILEPSY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MOOD; QUALITY OF LIFE; RATING SCALE; SCORING SYSTEM; SIDE EFFECT; AFFECT; MIDDLE AGED; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE; QUESTIONNAIRE; REFERENCE VALUE; REPRODUCIBILITY;

ADULT; AFFECT; ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS; EPILEPSY; FEMALE; HUMANS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; QUALITY OF LIFE; QUESTIONNAIRES; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; TRIAZINES;

EID: 15344344623     PISSN: 15255050     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yebeh.2004.07.005     Document Type: Article

References (34)

1. P. Ortinski K.J. Meador Cognitive effects of antiepileptic drugs Epilepsy Behav 5 Suppl. 1 2004 S60-S65
2. D. Smith G. Baker G. Davies D.W. Chadwick Outcomes of add-on treatment with lamotrigine in partial epilepsy Epilepsia 34 1993 312-322
3. Cramer JA, Arrigo C, Van Hammee G, Gauer LJ, Cereghino JJ, for the N132 Study Group. The effect of levetiracetam on epilepsy-related quality of life. Epilepsia 2000;41:868-874
4. D.M. McNair M. Loor L.F. Droppelman Profile of Mood States 1981 Educational and Industrial Testing Service San Diego, CA
5. Smith DB, Craft BR, Collins J, Mattson RH, Cramer JA, and the VA Cooperative Study Group 188. Behavioral characteristics of epilepsy patients compared with normal controls. Epilepsia 1986;27:760-8
6. G.A. Baker D.F. Smith M. Dewey A. Jacoby D.W. Chadwick The initial development of a health-related quality of life model as an outcome measure in epilepsy Epilepsy Res 16 1993 65-81
7. C.B. Dodrill J.L. Arnett K.W. Sommerville N.M. Sussman Evaluation of the effects of vigabatrin on cognitive abilities and quality of life in epilepsy Neurology 43 1993 2501-2507
8. B.G. Vickrey R.D. Hays J. Graber R. Rausch J. Engel R.H. Brook A health-related quality of life instrument for patients evaluated for epilepsy surgery Med Care 30 1992 299-331
9. O. Devinsky B.G. Vickrey J.A. Cramer et al. Development of the Quality of Life in Epilepsy Inventory Epilepsia 36 1995 1089-1104
10. A. Elixhauser N.K. Leidy K. Meador E. Means M.J. Willian The relationship between memory performance, perceived cognitive function, and mood in patients with epilepsy Epilepsy Res 37 1999 13-24
11. K. Perrine B.P. Hermann K.J. Meador et al. The relationship of neuropsychological functioning to quality of life in epilepsy Arch Neurol 52 1995 997-1003
12. D.L. Nyenhuis C. Yamamoto Adult and geriatric normative data and validation of the Profile of Mood States J Clin Psychol 55 1999 79-86
13. A.T. Beck C.H. Ward M. Mendelson J.E. Mock J.K. Erbaugh An inventory for measuring depression Arch Gen Psychiatry 4 1961 561-571
14. C.D. Spielberger R.L. Gorsuch R.E. Lushene The State-Trait Anxiety Inventory 1970 Consulting Psychologist Press Palo Alto, CA
15. R.A. Stern Visual Analog Mood Scales 1997 Psychological Assessment Resources Odessa, FL
16. J.A. Cramer K. Perrine O. Devinsky L. Bryant-Comstock K. Meador B.P. Hermann Development and cross-cultural translation of a 31-item quality of life questionnaire (QOLIE-31) Epilepsia 39 1998 81-88
17. J.E. Ware SF-36 Health Survey: Manual and Interpretation Guide 1993 Health Institute Boston Sec. 3.9
18. L.E. Kazis J.J. Anderson R.F. Meenan Effect sizes for interpreting changes in health status Med Care 27 1989 S178-89
19. J. Cohen Statistical power analyses for the behavioral sciences 1969 Academic Press London
20. G. Guyatt S. Walter G. Norman Measuring change over time: Assessing the usefulness of evaluative instruments J Chronic Dis 40 1987 178-181
21. J.A. Cramer A.E. Hammer R.P. Kustra Quality of life improvement with conversion to lamotrigine monotherapy Epilepsy Behav 5 2004 224-230
22. V. Pulliainen P. Kuikka H. Kalsa Are negative mood states associated with cognitive function in newly diagnosed patients with epilepsy? Epilepsia 41 2000 421-425
23. R. Martin K. Meador L. Turrentine et al. Comparative cognitive effects of carbamazepine and gabapentin in healthy senior adults Epilepsia 42 2001 764-771
24. K.R. Edwards J.C. Sackellares A. Vuong A.E. Hammer P.S. Barrett Lamotrigine monotherapy improves depressive symptoms in epilepsy: A double-blind comparison with valproate Epilepsy Behav 2 2000 28-36
25. J.C. Sackellares W.J. Kwong A. Vuong A.E. Hammer P.S. Barrett Lamotrigine monotherapy improves health-related quality of life in epilepsy: A double-blind comparison with valproate Epilepsy Behav 3 2002 376-382
26. B.J. Mason J.H. Kocsis A.C. Leon Measurement of severity and treatment response in dysthymia Psychiatr Ann 23 1993 625-631
27. Ettinger A, Reed M, Cramer J, Fanning K. for the Epilepsy Impact Project Group. Depression and co-morbidity in community-based patients with epilepsy or asthma. Neurology, in press
28. J.A. Cramer D. Blum M. Reed K. Fanning for the Epilepsy Impact Project Group, The influence of comorbid depression on quality of life for people with epilepsy Epilepsy Behav 4 2003 515-521
29. J.A. Cramer G.A. Baker A. Jacoby Development of a new seizure severity questionnaire: Initial reliability and validity testing Epilepsy Res 48 2002 187-197
30. J.A. Cramer D. Blum M. Reed K. Fanning for the Epilepsy Impact Project Group. The influence of comorbid depression on seizure severity Epilepsia 44 2003 1578-1584
31. J.A. Cramer D. Blum K. Fanning M. Reed for the Epilepsy Impact Project Group. The impact of comorbid depression on health resource utilization in a community sample of people with epilepsy Epilepsy Behav 5 2004 337-342
32. R.C. Kessler K.A. McGonagle S. Zhao et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey Arch Gen Psychiatry 51 1994 8-19
33. D. Blumer Antidepressant and double antidepressant treatment for the affective disorder of epilepsy J Clin Psychiatry 58 1997 3-11
34. T.A. Ketter R.M. Post W.H. Theodore Positive and negative psychiatric effects of antiepileptic drugs in patients with seizure disorders Neurology 53 Suppl. 2 1995 S53-S67